Article
Establishment of a human induced stem cell line (FUi002-A) from Dravet syndrome patient carrying heterozygous R1525X mutation in SCN1A gene.
Stem cell research - 1 Aug 2018
Tanaka Yasuyoshi, Higurashi Norimichi, Shirasu Naoto, Yasunaga Shin'ichiro, Moreira Kevin Mello, Okano Hideyuki, Hirose Shinichi
Abstract excerpt
De novo mutations in SCN1A are the most common cause of Dravet syndrome (DS), an infantile-onset epileptic encephalopathy. In this study, human induced pluripotent stem cell (hiPSC) line FUi002-A was generated from skin fibroblasts obtained from a clinically diagnosed 26-year-old male DS patient with the R1525X variant of the SCN1A gene. Skin fibroblasts were reprogrammed using OriP/EBNA-1 based episomal plasmids...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
